Evaluation of the effect of erenumab on migraine‐specific questionnaire in patients with chronic and episodic migraine

• Main Authors: Po‐Wei Chen (Author), Mats O. Karlsson (Author), Sebastian Ueckert (Author), Ari Pritchard‐Bell (Author), Cheng‐Pang Hsu (Author), Sandeep Dutta (Author), Malidi Ahamadi (Author)
• Format: Book
• Published: Wiley, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Erenumab is a fully human anti‐canonical calcitonin gene‐related peptide receptor monoclonal antibody approved for migraine prevention. The Migraine‐Specific Quality‐of‐Life Questionnaire (MSQ) is a 14‐item patient‐reported outcome instrument that measures the impact of migraine on health‐r...